AMH and polycystic ovary syndrome: Moreover, the fact that serum AMH levels are lower in PCOS women with a hyperandrogenic normo-ovulatory phenotype, compared to women with a non-hyperandrogenic oligo-anovulatory phenotype [60], shows that AMH can act independently of androgens on the ovulation defects of women with PCOS.